The aim of this study was to compare the visual analysis of attenuation-cor
rected and noncorrected F-18-fluoro-2-deoxy-D-glucose (FDG) PET images in p
atients with primary or metastatic breast cancer using standardized film do
cumentation and to evaluate the influence of attenuation correction on lesi
on detectability. Methods: Standard FDG PET of the breasts and of the axill
ary regions was performed on 28 women with breast cancer. Transmission scan
s were acquired for attenuation correction after administration of FDG. Tra
nsverse and coronal slices and maximum intensity projections both with and
without attenuation correction were documented in a standardized manner on
film. Noncorrected images were displayed with an upper threshold of five ti
mes the mean activity in normal lung tissue. Attenuation-corrected images w
ere documented with an upper threshold of a standardized uptake value of fi
ve. Two independent nuclear medicine physicians, who were unaware of the re
sults of clinical investigation, other imaging modalities and histopatholog
ic findings, interpreted the images visually, noncorrected images first. Re
sults: One hundred eighty-four of 189 lesions in 28 of 28 patients were fou
nd on attenuation-corrected and noncorrected images. Seventeen lesions were
found in the breasts of 12 patients, In 18 patients, 31 axillary lesions w
ere round. Moreover, 141 lesions representing distant metastases were detec
ted in 18 patients. Attenuation-corrected images showed the same lesions in
all patients but 2, in whom 5 of 189 small pulmonary lesions (2.6%) were n
ot detected. Iterative reconstruction did not improve detectability of thes
e lesions on attenuation-corrected images. These lesions were confirmed by
CT, which revealed diameters of <1 cm. Conclusion: Attenuation correction b
y transmission measurement after injection may impair lesion detectability
in PET for staging of breast cancer patients. When using the image modaliti
es described, noncorrected PET images should be considered in image analysi
s.